Molecular pathology of chondroid neoplasms: Part 1, benign lesions

Skeletal Radiology

Volumn 35, Issue 11, 2006, Pages 805-813

  Bell, W C ^a   Klein, M J ^a   Pitt, M J ^b   Siegal, G P ^b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Bizarre parosteal osteochondromatous proliferation; Chondroblastoma; Chondroma; Chondromyxoid fibroma; Cytogenetics; Molecular genetics; Osteochondroma

Indexed keywords

GENE PRODUCT; GENOMIC DNA; GLYCOSYLTRANSFERASE; NERVE CELL ADHESION MOLECULE; PARATHYROID HORMONE RECEPTOR 1; PARATHYROID HORMONE RELATED PROTEIN; PROTEIN BCL 2; PROTEIN EXT1; PROTEIN EXT2; SONIC HEDGEHOG PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

BENIGN TUMOR; CARTILAGE TUMOR; CHONDROBLASTOMA; CHONDROMA; CHONDROMYXOID TUMOR; CHONDROSARCOMA; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME BANDING PATTERN; CHROMOSOME LOSS; CHROMOSOME TRANSLOCATION; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; ENCHONDROMATOSIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE LOCATION; GENE MUTATION; HEREDITARY MULTIPLE EXOSTOSIS; HIGH RISK PATIENT; HUMAN; KARYOTYPE; MOLECULAR CLONING; MOLECULAR GENETICS; OSTEOCHONDROMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW;

BIOLOGICAL MARKERS; BONE NEOPLASMS; CHONDROMA; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENETIC TESTING; HUMANS;

EID: 33749400674     PISSN: 03642348     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00256-006-0191-4     Document Type: Review

References (41)

1. Caspersson T, Zech L, Johansson C, Lindsten J, Hulten M. Fluorescent staining of heteropycnotic chromosome regions in human interphase nuclei. Exp Cell Res 1970;61(2):472-4.
2. Harper ME, Saunders GF. Localization of single copy DNA sequences of G-banded human chromosomes by in situ hybridization. Chromosoma 1981;83(3):431-9.
3. Pinkel D, Straume T, Gray JW. Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization. Proc Nat Acad Sci USA 1986;83(9):2934-8.
4. Schrock E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, et al. Multicolor spectral karyotyping of human chromosomes. Science 1996;273(5274):494-7.
5. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-21.
6. Burnette WN. "Western blotting": Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981;112:195-203.
7. Grizzle WE, Myers RB, Manne U, Srivastava S. Immunohistochemical evaluation of biomarkers in prostatic and colorectal neoplasia. In: Hanausek M, Walaszek Z (eds) Methods in molecular medicine-tumor marker protocols, Humana Press, Totowa, NJ, 1998;pp. 143-60.
8. Hutchen TW, Yip TT. New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Commun Mass Spectrom 1993;7:576-80.
9. 1 Fechner RE, Mills SE. Cartilaginous lesions. In: Atlas of tumor pathology, tumors of the bones and joints. Armed Forces Institute Pathol 1993;pp 79-128.
10. Bridge JA, Persons DL, Neff JR, Bhatia P. Clonal karyotypic aberrations in enchondroma. Cancer Detec Prev 1992;16(4):215-19.
11. Sawyer JR, Swanson CM, Lukacs JL, Nicholas RW, North PE, Thomas JR. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors. Cancer 1998;82(3):474-83.
12. Buddingh EP, Naumann S, Nelson M, Neffa JR, Birch N, Bridge JA. Cytogenetic findings in benign cartilaginous neoplasms. Cancer Gene Cytogene 2003;141(2):164-8.
13. Dal Cin P, Qi H, Sciot R, Van den Berghe H. Involvement of chromosomes 6 and 11 in a soft tissue chondroma. Cancer Gene Cytogene 1997;93(2):177-8.
14. Shadan FF, Mascarello JT, Newbury RO, Dennis T, Spallone P, Stock AD. Supernumerary ring chromosomes derived from the long arm of chromosome 12 as the primary cytogenetic anomaly in a rare soft tissue chondroma. Cancer Gene Cytogene 2000;118(2):144-7.
15. Dahlen A, Mertens F, Rydholm A, Brosjo O, Wejde J, Mandahl N, et al. Fusion, disruption, and expression of HMGA2 in bone and soft tissue chondromas. Mod Pathol 2003;16:1132-40.
16. Ozaki T, Wai D, Schafer KL, Lindner N, Bocker W, Winkelmann W, Dockhorn-Dworniczak B. Poremba C. Comparative genomic hybridization in cartilaginous tumors. Anticancer Res 2004;24:1721-25.
17. Rozeman LB, Hameetman L, Cleton-Jansen AM, Taminiau AH, Hogendoorn PC, Bovee JV. Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas. J Pathol 2005;205(4):476-82.
18. Ozisik YY, Meloni AM, Spanier SS, Bush CH, Kingsley KL, Sandberg AA. Deletion 1p in a low-grade chondrosarcoma in a patient with Ollier disease. Cancer Gene Cytogene 1998;105:128-33.
19. Amling M, Posl M, Hentz MW, Priemel M, Delling G. PTHrP an Bcl-2: essential regulatory molecules in chondrocyte differentiation and chondrogenic tumors. Verh Dtsch 1998;82:160-9.
20. Rozeman LB, Sangiorgi L, Briaire-de Bruijn IH, Mainil-Varlet P, Bertoni F, Cleton-Jansen AM, et al. Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150C. Human Mutat 2004;24(6):466-73.
21. Hopyan S, Gokgoz N, Poon R, Gensure RC, Yu C, Cole WG, et al. A mutant PTH/PTHrP type I receptor in enchondromatosis. Nat Genet 2002;30(3):306-10.
22. Kusuzaki K, Murata H, Takeshita H, Hirata M, Hashiguchi S, Tsuji Y, et al. Mod Pathol 1999;12(9):863-72.
23. Bridge JA, Nelson M, Orndal C, Bhatia P, Neff JR. Clonal karyotypic abnormalities of the hereditary multiple exostoses chromosomal loci 8q24.1 (EXT1) and 11p11-12 (EXT2) in patients with sporadic and hereditary osteochondroma. Cancer 1998;82:1657-63.
24. Wuyts W, Van Hul W. Molecular basis of multiple exostoses: Mutations in the EXT1 and EXT2 genes. Human Mutat 2000;15:220-7.
25. Bernard MA, Hall CE, Hogue DA, Cole WG, Scott A, et al. Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostoses chondrocytes. Cell Motil Cytoskelet 2001;48:149-62.
26. Wuyts W, Van Hul W, Wauters J, Nemtsova M, et al. Postitional cloning of a gene involved in hereditary multiple exostoses. Hum Mol Gene 1996;5:1547-57.
27. Ahn J, Ludecke H, Lindow S, Horton WA, Lee B, Wagner MJ, et al. Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1). Nat Gene 1995;11:137-43.
28. McCormick C, Duncan G, Goutsos T, Tufaro F. The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparin sulfate. Proc Nat Acad Sci USA 2000;97:668-73.
29. Duncan G, McCormick C, Tufaro F. The link between heparin sulfate and hereditary bone disease: Finding a function for the EXT family of putative tumor suppressor proteins. J Clin Invest 2001;108:511-6.
30. Lin X, Wei G, Shi Z, Dryer L, Esko JD, Wells DE, et al. Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. Dev Biol 2000;224:299-311.
31. Sjogren H, Orndal C, Tingby O, Meis-Kindblom JM, Kindblom LG, Stenman G. Cytogenetic and spectral karyotype analyses of benign and malignant cartilage tumours. Int J Oncol 2004;24:1385-91.
32. Halbert AR, Harrison WR, Hicks MJ, Davino N, Cooley LD. Cytogenetic analysis of a scapular chondromyxoid fibroma. Cancer Gene Cytogene 1998;104:52-6.
33. Granter SR, Renshaw AA, Kozadewich HP, Fletcher JA. The pericentromeric inversion, inv (6)(p25q13), is a novel diagnostic marker in chondromyxoid fibroma. Mod Pathol 1998;11:1071-74.
34. Safar A, Nelson M, Neff JR, Maale GE, Bayani J, Squire J, et al. Recurrent anomalies of 6q25 in chondromyxoid fibroma. Human Pathol 2000;31:306-11.
35. Romeo S, Bovee JV, Grogan SP, Taminiau AH, Eilers PH, Cleton-Jansen AM, et al. Chondromyxoid fibroma resembles in vitro chondrogenesis, but differs in expression of signalling molecules. J Pathol 2005;206:135-42.
36. Swarts SJ, Neff JR, Johansson SL, Nelson M, Bridge JA. Significance of abnormalities of chromosomes 5 and 8 in chondroblastoma. Clin Orthop Relat Res 1998;349:189-93.
37. van Zelderen-Bhola SL, Bovee JV, Wessels HW, Mollevanger P, Nijhuis JV, van Eendenburg JD, et al. Ring chromosome 4 as the sole cytogenetic anomaly in a chondroblastoma: A case report and review of the literature. Cancer Gene Cytogene 1998;105:109-12.
38. Aigner T, Loos S, Inwards C, Perris R, Perissinotto D, Unni KK, et al. Chondroblastoma is an osteoid-forming, but not cartilage-forming neoplasm. J Pathol 1999;189:463-9.
39. Nora FE, Dahlin DC, Beabout JW. Bizarre parosteal osteochondromatous proliferations of the hands and feet. Am J Surg Pathol 1983;51:245-50.
40. Nilsson M, Domanski HA, Mertens F, Mandahl N. Molecular cytogenetic characterization of recurrent translocation breakpoints in bizarre parosteal osteochondromatous proliferation (Nora's lesion). Hum Pathol 2004;35:1063-9.
41. Zambrano E, Nose V, Perez-Atayde AR, Gebhardt M, Hresko MT, Kleinman P, et al. Distinct chromosomal rearrangements in subungual (Dupuytren) exostosis and bizarre parosteal osteochondromatous proliferation (Nora's lesion). Am J Surg Pathol 2004;28:1033-9.